Moasser MM - Search Results

1

Resiliency and vulnerability in the HER2-HER3 tumorigenic driver.

Amin DN, Sergina N, Ahuja D, McMahon M, Blair JA, Wang D, Hann B, Koch KM, Shokat KM, Moasser MM. Amin DN, et al. Among authors: moasser mm. Sci Transl Med. 2010 Jan 27;2(16):16ra7. doi: 10.1126/scitranslmed.3000389. Sci Transl Med. 2010. PMID: 20371474 Free PMC article.

2

Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3.

Sergina NV, Rausch M, Wang D, Blair J, Hann B, Shokat KM, Moasser MM. Sergina NV, et al. Among authors: moasser mm. Nature. 2007 Jan 25;445(7126):437-41. doi: 10.1038/nature05474. Epub 2007 Jan 7. Nature. 2007. PMID: 17206155 Free PMC article.

3

The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis.

Moasser MM. Moasser MM. Oncogene. 2007 Oct 4;26(45):6469-87. doi: 10.1038/sj.onc.1210477. Epub 2007 Apr 30. Oncogene. 2007. PMID: 17471238 Free PMC article. Review.

4

Targeting the function of the HER2 oncogene in human cancer therapeutics.

Moasser MM. Moasser MM. Oncogene. 2007 Oct 11;26(46):6577-92. doi: 10.1038/sj.onc.1210478. Epub 2007 May 7. Oncogene. 2007. PMID: 17486079 Free PMC article. Review.

5

Targeting HER proteins in cancer therapy and the role of the non-target HER3.

Hsieh AC, Moasser MM. Hsieh AC, et al. Among authors: moasser mm. Br J Cancer. 2007 Aug 20;97(4):453-7. doi: 10.1038/sj.bjc.6603910. Epub 2007 Jul 31. Br J Cancer. 2007. PMID: 17667926 Free PMC article. Review.

6

Improved tumor vascular function following high-dose epidermal growth factor receptor tyrosine kinase inhibitor therapy.

Moasser MM, Wilmes LJ, Wong CH, Aliu S, Li KL, Wang D, Hom YK, Hann B, Hylton NM. Moasser MM, et al. J Magn Reson Imaging. 2007 Dec;26(6):1618-25. doi: 10.1002/jmri.21196. J Magn Reson Imaging. 2007. PMID: 17968965 Free PMC article.

7

The HER family and cancer: emerging molecular mechanisms and therapeutic targets.

Sergina NV, Moasser MM. Sergina NV, et al. Among authors: moasser mm. Trends Mol Med. 2007 Dec;13(12):527-34. doi: 10.1016/j.molmed.2007.10.002. Epub 2007 Nov 5. Trends Mol Med. 2007. PMID: 17981505 Free PMC article. Review.

8

The epidermal growth factor receptor family: biology driving targeted therapeutics.

Wieduwilt MJ, Moasser MM. Wieduwilt MJ, et al. Among authors: moasser mm. Cell Mol Life Sci. 2008 May;65(10):1566-84. doi: 10.1007/s00018-008-7440-8. Cell Mol Life Sci. 2008. PMID: 18259690 Free PMC article. Review.

9

A chemical screen in diverse breast cancer cell lines reveals genetic enhancers and suppressors of sensitivity to PI3K isoform-selective inhibition.

Torbett NE, Luna-Moran A, Knight ZA, Houk A, Moasser M, Weiss W, Shokat KM, Stokoe D. Torbett NE, et al. Biochem J. 2008 Oct 1;415(1):97-110. doi: 10.1042/BJ20080639. Biochem J. 2008. PMID: 18498248 Free PMC article.

10

Phosphorylation of the SRC epithelial substrate Trask is tightly regulated in normal epithelia but widespread in many human epithelial cancers.

Wong CH, Baehner FL, Spassov DS, Ahuja D, Wang D, Hann B, Blair J, Shokat K, Welm AL, Moasser MM. Wong CH, et al. Among authors: moasser mm. Clin Cancer Res. 2009 Apr 1;15(7):2311-22. doi: 10.1158/1078-0432.CCR-08-2533. Epub 2009 Mar 24. Clin Cancer Res. 2009. PMID: 19318475 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

92 results

Search Page